申请人:METABOLON, INC.
公开号:US20150065366A1
公开(公告)日:2015-03-05
Methods for identifying and evaluating biochemical entities useful as biomarkers for bladder cancer, target identification/validation, and monitoring of drug efficacy are provided. Also provided are suites of small molecule entities as biomarkers for bladder cancer.